1. Home
  2. TNXP vs WILC Comparison

TNXP vs WILC Comparison

Compare TNXP & WILC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • WILC
  • Stock Information
  • Founded
  • TNXP 2007
  • WILC 1994
  • Country
  • TNXP United States
  • WILC Israel
  • Employees
  • TNXP N/A
  • WILC N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • WILC Food Distributors
  • Sector
  • TNXP Health Care
  • WILC Consumer Discretionary
  • Exchange
  • TNXP Nasdaq
  • WILC Nasdaq
  • Market Cap
  • TNXP 207.5M
  • WILC 225.4M
  • IPO Year
  • TNXP N/A
  • WILC 1997
  • Fundamental
  • Price
  • TNXP $39.78
  • WILC $15.98
  • Analyst Decision
  • TNXP Strong Buy
  • WILC
  • Analyst Count
  • TNXP 2
  • WILC 0
  • Target Price
  • TNXP $585.00
  • WILC N/A
  • AVG Volume (30 Days)
  • TNXP 1.3M
  • WILC 3.5K
  • Earning Date
  • TNXP 05-12-2025
  • WILC 05-19-2025
  • Dividend Yield
  • TNXP N/A
  • WILC 3.64%
  • EPS Growth
  • TNXP N/A
  • WILC 80.33
  • EPS
  • TNXP N/A
  • WILC 1.37
  • Revenue
  • TNXP $10,041,000.00
  • WILC $157,003,357.00
  • Revenue This Year
  • TNXP $12.17
  • WILC N/A
  • Revenue Next Year
  • TNXP $789.15
  • WILC N/A
  • P/E Ratio
  • TNXP N/A
  • WILC $11.62
  • Revenue Growth
  • TNXP N/A
  • WILC 10.73
  • 52 Week Low
  • TNXP $6.76
  • WILC $8.18
  • 52 Week High
  • TNXP $558.08
  • WILC $17.58
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 74.56
  • WILC 55.42
  • Support Level
  • TNXP $25.40
  • WILC $15.64
  • Resistance Level
  • TNXP $37.84
  • WILC $16.55
  • Average True Range (ATR)
  • TNXP 4.17
  • WILC 0.39
  • MACD
  • TNXP 1.75
  • WILC 0.03
  • Stochastic Oscillator
  • TNXP 87.00
  • WILC 53.66

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About WILC G. Willi-Food International Ltd.

G. Willi-Food International Ltd is a company engaged in high-quality, great-tasting kosher food products. The Company is engaged, directly and through subsidiaries, with one segment Import-export, marketing, and distribution of food products. The principal product line includes Canned Vegetables and Pickles, Canned Fish, Canned Fruit, Edible Oils, Dairy and Dairy Substitute Products, Dried Fruit, Nuts and Beans, and Other Products. Its brands include Willi-Food, Euro European Dairies, Donna Rozza, Manchow, Gold Frost, Tifeeret, The Chef Dish, Art Coffe, Mr. Chang, Muchi, Euro Butter, Euro Spread, Euro Cheese, Euro Cream, Euro Dessert, Euro Veg, Ha-Bulgaria, Gelato, and Emma.

Share on Social Networks: